Megazol
 | |
| Systematic (IUPAC) name | |
|---|---|
|
2-Amino-5-(1-methyl-5-nitro-2-imidazolyl)-1,3,4-thiadiazole | |
| Identifiers | |
| CAS Number | 19622-55-0 |
| ChemSpider | 27598 |
| Chemical data | |
| Formula | C6H6N6O2S |
| Molar mass | 226.22 g/mol |
| |
Megazol (CL 64855) is a nitroimidazole based drug that cures some protozoan infections.
A study of nitroimidazoles found the drug extremely effective against T. brucei and T. cruzi which cause Chagas disease and African sleeping sickness, respectively. The drug is considerably more effective than standard benznidazole therapy (for Chagas) which is considered the gold standard.[1] This is despite that other nitroimidazoles proved ineffective against these pathogens.
References
- ↑ "Activation of Benznidazole by Trypanosomal Type I Nitroreductases Results in Glyoxal Formation". Antimicrob. Agents Chemother. 56 (1): 115–123. 2012. doi:10.1128/AAC.05135-11.
This article is issued from Wikipedia - version of the Friday, February 26, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.